Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2009 3
2010 1
2011 3
2012 3
2013 1
2015 4
2016 3
2017 5
2018 5
2019 5
2020 9
2021 6
2022 9
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
[Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with ischemic stroke].
Zhuravleva MV, Shchukin IA, Fidler MS, Prokofiev AB, Serebrova SY, Vasyukova NS, Demchenkova EY, Arkhipov VV. Zhuravleva MV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(12. Vyp. 2):60-66. doi: 10.17116/jnevro202012012260. Zh Nevrol Psikhiatr Im S S Korsakova. 2020. PMID: 33449535 Review. Russian.
In clinical practice it's important to follow conditions, where neuroprotection will have maximum safety and effectiveness. The clinical trials of ethylmethylhydroxypyridine succinate (mexidol) in patients with acute ischemic stroke are described in the present revi …
In clinical practice it's important to follow conditions, where neuroprotection will have maximum safety and effectiveness. The clinical tri …
[Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].
Zhuravleva MV, Prokofiev AB, Serebrova SY, Vasyukova NS, Demchenkova EY, Arkhipov VV. Zhuravleva MV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(6):119-124. doi: 10.17116/jnevro2020120061119. Zh Nevrol Psikhiatr Im S S Korsakova. 2020. PMID: 32678558 Review. Russian.
The results of a series of clinical studies on the use of ethylmethylhydroxypyridine succinate (mexidol) in patients with CCI are analyzed. ...
The results of a series of clinical studies on the use of ethylmethylhydroxypyridine succinate (mexidol) in patients with CCI …
[An effect of ethylmethylhydroxypyridine succinate and ethylmethylhydroxypyridine malate on changes in mitochondrial function under conditions of focal cerebral ischemia].
Pozdnyakov DI, Zolotykh DS, Vihor AA. Pozdnyakov DI, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(11):111-116. doi: 10.17116/jnevro2023123111111. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37994896 Russian.
OBJECTIVE: To evaluate an effect of ethylmethylhydroxypyridine succinate and ethylmethylhydroxypyridine malate on changes in mitochondrial function under experimental focal cerebral ischemia. ...The restoration of mitochondrial energy function was also shown with th …
OBJECTIVE: To evaluate an effect of ethylmethylhydroxypyridine succinate and ethylmethylhydroxypyridine malate on changes in m …
Postcovid-19 Asthenic Syndrome.
Zolotovskaia IA, Shatskaia PR, Davydkin IL, Shavlovskaya OA. Zolotovskaia IA, et al. Neurosci Behav Physiol. 2022;52(2):191-195. doi: 10.1007/s11055-022-01222-6. Epub 2022 Mar 18. Neurosci Behav Physiol. 2022. PMID: 35317270 Free PMC article.
The envelope method was used to randomize patients into two groups: the study group (n = 64) received ethylmethylhydroxypyridine succinate (Neurox) 1 tablet (125 mg) three times daily for four weeks; medications in the reference group (n = 65) did not include any su …
The envelope method was used to randomize patients into two groups: the study group (n = 64) received ethylmethylhydroxypyridine s …
[Post-COVID-19 asthenic syndrome].
Zolotovskaia IA, Shatskaia PR, Davydkin IL, Shavlovskaya OA. Zolotovskaia IA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(4):25-30. doi: 10.17116/jnevro202112104125. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34037351 Clinical Trial. Russian.
Patients were randomized into two groups: in the main group (n=64), ethylmethylhydroxypyridine succinate (Neurox) was prescribed 1 tablet (125 mg) 3 times a day for 4 weeks; in the comparison group (n=65), medical drugs (MD) did not contain substances from the pharm …
Patients were randomized into two groups: in the main group (n=64), ethylmethylhydroxypyridine succinate (Neurox) was prescrib …
[Investigation of the effect of ethylmethylhydroxypyridine succinate on the effectiveness of non-steroidal anti-inflammatory drugs for visceral and somatic pain in mice and rats].
Ivanova EA, Vasilchuk AG, Matyushkin AI, Voronina TA. Ivanova EA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(12):124-132. doi: 10.17116/jnevro2023123121124. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 38147392 Russian.
OBJECTIVE: To study the effect of ethylmethylhydroxypyridine succinate (EMHPS) on the analgesic effect of the non-selective cyclooxygenase (COX) inhibitor diclofenac sodium and the selective COX-2 inhibitor etoricoxib in models of acute visceral and somatic pain and …
OBJECTIVE: To study the effect of ethylmethylhydroxypyridine succinate (EMHPS) on the analgesic effect of the non-selective cy …
76 results